SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant x
Filed by a party other than the Registrant ¨
Check the appropriate box:
¨ Preliminary Proxy Statement ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 |
¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |||
Alere Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
x No fee required.
¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
¨ Fee paid previously with preliminary materials:
¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number of the Form or Schedule and the date of its filing.
(1) Amount previously paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
ALERE REVIEWS POOR TRACK RECORD OF COPPERSMITHS CO-FOUNDER AFTER
HIS FUNDS NOMINEES ATTAIN BOARD SEATS
Urges Stockholders to Vote the WHITE Proxy Card to Elect Aleres Four New Independent Director
Nominees
WALTHAM, Mass., July 17, 2013 Alere Inc. (NYSE: ALR) (the Company or Alere), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health information solutions, today announced that it has issued a letter to stockholders in connection with the Companys 2013 Annual Meeting of Stockholders, to be held on August 7, 2013, and also made related materials available on its website at http://www.alere.com/us/en/about/investor-relations/annual-meetings-reports.html.
The full text of the letter follows:
July 17, 2013
Dear Fellow Alere Stockholder:
At Aleres August 7, 2013 Annual Meeting of Stockholders, you will have an important decision to make about the future of your investment in Alere. Your Board and management team would like to make sure you have all of the facts before casting your vote.
As you know, Coppersmith, a New York-based hedge fund, is attempting to place three of its nominees on the Alere Board and is advocating a strategy that we believe is potentially value destructive. Our serious reservations about Coppersmiths plan are heightened because Coppersmith was formed approximately one year ago, it has no track record of its own and its co-founders prior track record is poor.
Given that Coppersmith has publicly disclosed only very limited information about itself, we have focused on its co-founders predecessor firm MMI Investments, L.P. (MMI)i. Since 2008, MMI obtained Board seats for its nominees at three companies following proxy contests:
Company |
Board Member |
Tenure Start Date |
Tenure End Dateii |
Total Returniii |
Total Return Relative to Market Indexiv |
Total Return Relative to Sector Indexv | ||||||
DHT Holdings |
Robert N. Cowen | 5/14/2010 | Current | (88.6%) | (140.1%) | (30.5%) | ||||||
Unisys Corporation | Clay Lifflander | 5/20/2008 | 12/7/2010 | (44.0%) | (35.9%) | (51.1%) | ||||||
Charles McQuade | 5/20/2008 | 5/1/2012 | (58.0%) | (66.7%) | (108.3%) | |||||||
Brinks Company | Carrol Wetzel & Robert Strang | 5/2/2008 | 5/6/2011 | 18.4% | (3.8%) | (2.5%) | ||||||
Average Underperformance: | (70.2%) | (47.1%) |
At two of these three companies, the stock price fell dramatically (declines of 91% and 58%, respectively) during the tenure of MMIs director candidates on the board. In addition, at all three of these companies, stockholder returns during the tenure of MMIs director candidates underperformed the relevant market and sector indices for each company, underperforming on average by 70% and 47%, respectively.
Given Mr. Landes and MMIs poor record of improving stock price performance after a successful election contest, Alere stockholders should have very serious concerns about electing any of Coppersmiths nominees. We believe these paid nominees will single-mindedly implement Coppersmiths value-destructive plan to divest and delever at all costs.
On the other hand, your Boards nominees are truly independent. There were no pre-conditions to their selection, and the Nominating and Corporate Governance Committee focused on the CEO and healthcare operating experience of potential nominees, and whether this experience would enable them to add significant value to Aleres Board. We believe that your Boards nominees will rely on their substantial experience leading and building successful healthcare companies and serving as public-company Board members to objectively evaluate the right strategy in order for Alere to continue to improve stockholder value.
A chart comparing certain key characteristics of the Alere and Coppersmith nominees follows:
Your Boards Nominees | Healthcare CEO Experience |
Public Board Experience |
Extensive CEO Experience Integrating Acquisitions |
Extensive CEO Experience Driving Growth in Foreign Emerging Markets |
Extensive CEO Experience Developing, Getting FDA Approved & Launching Medical Products | |||||
Haken Bjorklund, Ph.D. |
yes | yes | yes | yes | yes | |||||
Stephen P. MacMillan |
yes | yes | yes | yes | yes | |||||
Brian A. Markinson |
yes | yes | yes | yes | yes | |||||
Sir Thomas McKillop |
yes | yes | yes | yes | yes | |||||
Coppersmiths Nominees |
||||||||||
Curt Hartman |
No* | No | No | No | No | |||||
Theodore Martin |
No | Yes | No | No | No | |||||
Jerome Lande |
No | No | No | No | No |
* Excludes eight months as interim CEO.
We have provided additional materials that summarize our analysis of the track-record of MMI when its nominees were elected to a companys board of directors. These slides can be accessed on our website at http://www.alere.com/us/en/about/investor-relations/annual-meetings-reports.html.
Your Board recommends that you vote FOR its nominees using the WHITE proxy card today.
We appreciate and look forward to your continued support.
Sincerely, |
Ron Zwanziger |
Chairman, Chief Executive Officer and President |
If you have any questions, require assistance with voting your WHITE proxy card, or need
additional copies of the proxy materials, please contact:
The Proxy Advisory Group, LLC
18 East 41st Street, Suite 2000
New York, New York 10017
(888) 337-7699
Or
(888) 33 PROXY
Forward-Looking Statements
This letter contains forward-looking statements within the meaning of the federal securities laws, including statements regarding our strategy, anticipated improvements in stockholder value, the timing of the Annual Meeting and the anticipated independence of Aleres nominees. These statements reflect our current views with respect to future events and are based on managements current assumptions and information currently available. Actual results may differ materially due to numerous factors including, without limitation, risks associated with global market and economic conditions and our ability to execute on our strategy, unanticipated effects of the Affordable Care Act, disruptions in the capital markets, fluctuations in currency exchange rates, changes in laws and regulations, dependence on suppliers, potential product liability litigation, regulatory compliance costs, unanticipated cost increases, competition, unanticipated delays or difficulties in research and product development and changes in demand for our products, as well as the other risks described in the Risk Factors section of our Annual Report on Form 10-K filed with the SEC on March 1, 2013, as amended. We undertake no obligation to update any forward-looking statements contained herein.
Contacts:
Kelly Sullivan / Annabelle Rinehart / Dan Moore
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449
i | Jerome Lande, co-founder of Coppersmith and one of its nominees to Aleres Board, previously served as a vice president of MCM Capital Management LLC. This organization, now defunct, was the general partner of MMI, where Lande claims he was responsible for all areas of portfolio management. |
ii | DHT Holdings: Robert N. Cowens current tenure expires in 2014; returns taken as of June 28, 2013. Unisys Corporation: Clay Lifflander resigned from the Board on December 7, 2010 and Charles McQuade retired on May 1, 2012. Brinks Company: Carrol Wetzel and Robert Strang served adjacent terms on Brinks Board. Carrol Wetzel served beginning on 5/2/2008 and left on 10/31/2008 to serve on Board of Brinks Home Security Holdings, Inc., which was sold to Tyco on 5/14/2010, while Robert Strang served beginning on 10/31/2008 and left on 5/6/2011. |
iii | Returns from a third-party data source and represent total stockholder returns including price appreciation, dividends and stock splits. Unisys Corporation did not pay dividends during the period and therefore Total Return is price appreciation and stock splits. Brinks Total Return is based on market value weighted index return of combined Brinks from 5/2/2008 to 5/6/2011 and Brinks Home Security from 11/3/2008 spin-off from Brinks to 5/13/2010 close of sale to Tyco. |
iv | S&P 500 Index is used as DHT Holdings Market Index and the Total Return is 51.5% during Robert N. Cowens tenure. S&P 500 Index is used as Unisys Corporations Market Index and the Total Return is (8.1%) during Clay Lifflanders tenure and 8.7% during Charles McQuades tenure. S&P Midcap 400 Index is used as Brinks Companys Market Index and the Total Return is 22.2% during Carrol Wetzel and Robert Strangs adjacent tenure. |
v | VLCC Time Charter Rates is used as DHT Holdings Sector Index and the Total Return is (58.1%) during Robert N. Cowens tenure. S&P 500 IT Services Index is used as Unisys Corporations Sector Index and the Total Return is 7.1% during Clay Lifflanders tenure and 50.3% during Charles McQuades tenure. S&P Midcap 400 Commercial Services and Supplies Index is used as Brinks Companys Sector Index and the Total Return is 20.9% during Carrol Wetzel and Robert Strangs adjacent tenure. |